Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, According to Spherix Global Insights
July 18, 2024 10:05 ET
|
Spherix Global Insights
EXTON, PA, July 18, 2024 (GLOBE NEWSWIRE) -- In February of this year, Takeda’s Eohilia (budesonide oral suspension) received FDA approval as the first and only oral therapy for eosinophilic...
[Latest] Global Sterilization Services Market Size/Share Worth USD 12.49 Billion by 2033 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 10, 2024 13:30 ET
|
Custom Market Insights
Austin, TX, USA, July 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Sterilization Services Market Size, Trends and Insights By Method (Ethylene...
Splashtop Approaches 5x Growth in Healthcare & Pharmaceutical Sectors
July 10, 2024 11:00 ET
|
Splashtop Inc.
CUPERTINO, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Splashtop, a leader in secure remote access and IT support solutions, today announced a milestone achievement of 492% growth within the...
Global Pregelatinized Starch Market Size To Worth USD 2.95 Billion By 2033 | CAGR OF 4.55%
July 04, 2024 22:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , July 04, 2024 (GLOBE NEWSWIRE) -- The Global Pregelatinized Starch Market Size is to Grow from USD 1.89 Billion in 2023 to USD 2.95 Billion by 2033, at a Compound Annual...
Hydroxyapatite Market Size is Projected to Reach USD 4.4 billion, Garnering a 6.0% CAGR by 2034 | Exclusive Report by Transparency Market Research, Inc.
July 03, 2024 08:34 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. - , July 03, 2024 (GLOBE NEWSWIRE) -- The hydroxyapatite market was projected to attain US$ 2.3 billion in 2023. It is...
Olon Group Announces the Acquisition of GTP Bioways Group
July 03, 2024 04:30 ET
|
Olon SpA
OLON GROUP ANNOUNCES THE ACQUISITION
OF GTP BIOWAYS GROUP
GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufa
Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors
June 27, 2024 08:49 ET
|
Spherix Global Insights
Exton, Pennsylvania, June 27, 2024 (GLOBE NEWSWIRE) -- Prior to 2023, there was no treatment for GA, a progressive form of dry age-related macular degeneration that results in blindness. That...
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Continued Unmet Needs and Track New Launches
June 26, 2024 04:00 ET
|
Spherix Global Insights
EXTON, PA, June 26, 2024 (GLOBE NEWSWIRE) -- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disorder in which red blood cells prematurely break apart, a process known as hemolysis....
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
June 25, 2024 09:00 ET
|
Qure.ai Technologies Limited
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI.
Ophthalmologists Favor Genentech’s Vabysmo and Regeneron’s Eylea HD for Diabetic Macular Edema Treatment Despite Payer Constraints
June 24, 2024 09:27 ET
|
Spherix Global Insights
EXTON, PA., June 20, 2024, June 24, 2024 (GLOBE NEWSWIRE) -- The treatment landscape for Diabetic Macular Edema (DME) continues to evolve, with innovative therapies and emerging data significantly...